超普疝装置和普理灵疝装置修补腹股沟疝的对比  

Comparison between ultrapro hernia system and prolene hernia system in the treatment of inguinal hernia

作　　者：宋学民[1] 黄世锋[1] 

机构地区：[1]广西医科大学第四附属医院普外科,广西壮族自治区柳州市545005

出　　处：《中国组织工程研究》2012年第21期3873-3876,共4页Chinese Journal of Tissue Engineering Research

摘　　要：背景:重量型普理灵疝装置作为腹膜前间隙修补技术之一,在国内外已得到广泛应用,但有部分患者修补后出现疼痛、异物感。目的:探讨超普疝装置在腹股沟疝无张力修补中的应用价值。方法:选择2008-02/2010-12在广西医科大学第四附属医院普外科择期行单侧开放腹膜前腹股沟疝修补患者155例,根据使用修补装置不同分为超普疝装置组(n=79)和普理灵疝装置组(n=76),所有患者于术后3,6及12个月时进行随访。结果与结论:2组在手术时间、住院时间及发生并发症比例接近(P>0.05)。随访12个月,2组均未见复发病例。超普疝装置组患者术后疼痛评分与普理灵疝装置组接近(P>0.05)。但超普疝装置组异物不适感患者明显少于普理灵疝装置组(P<0.05)。说明超普疝装置腹股沟疝修补后患者局部异物不适感更轻,生活质量更高。BACKGROUND： Heavyweight prolene hernia system as an anterior approach to preperitoneal inguinal hernia repair has become a commonly used technique at home and abroad, but some patients still feel chronic pain and foreign body sensation. OBJECTIVE： To compare the clinical outcomes of ultrapro hernia system and prolene hernia system in inguinal hernia repair. METHODS： From February 2008 to December 2010, 155 patients with unilateral inguinal hernia were operated on with ultrapro hernia system （n=79） or prolene hernia system （n=76） devices. All patients were followed up 3, 6, and 12 months postoperatively. RESULTS AND CONCLUSION： There were no significant differences in operative time, hospital stay, and postoperative complications between the ultrapro hernia system and prolene hernia system groups （P 〉 0.05）. The average pain score in the ultrapro hernia system group was lower than that in the prolene hernia system group, but the difference was not statistically significant （P 〉 0.05）. More patients complained of foreign body sensation in the prolene hernia system group compared with the ultrapro hernia system group （P 〈 0. 05）. There was no recurrence in the two groups. Compared with the prolene hernia system, the ultrapre hernia system can provides less postoperative foreign body sensation and better quality of life in the treatment of inguinal hernia.

关 键 词：疝 腹股沟 疝修补 疼痛 异物感 

分 类 号：R318[医药卫生—生物医学工程]